Maximo F. Nougues - Nov 2, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
Chief Financial Officer
Signature
/s/ Gordon Esplin as attorney-in-fact for Maximo F. Nougues
Stock symbol
PBYI
Transactions as of
Nov 2, 2022
Transactions value $
-$367
Form type
4
Date filed
11/4/2022, 04:13 PM
Previous filing
Oct 5, 2022
Next filing
Dec 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale -$367 -163 -0.15% $2.25 111K Nov 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.